The impact of lipocalin-type-prostaglandin-D-synthase as a predictor of kidney disease in patients with type 2 diabetes

Beatriz Alves, Marcelo Bacci, Marina Cavallari, Ross Rozier-Alves, Fernando Fonseca
  • Drug Design Development and Therapy, June 2015, Dove Medical Press
  • DOI: 10.2147/dddt.s82100

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

open access logoRead Publication

http://dx.doi.org/10.2147/dddt.s82100

The following have contributed to this page: Beatriz Alves and Marcelo Bacci

In partnership with: